Osimertinib for Lung Cancer: What Is the Monthly Treatment Cost?

The price of Osimertinib varies depending on specifications, region, and medical insurance policies. Currently, the cost per box ranges from thousands to tens of thousands of yuan. As a prescription drug, it must be used strictly under a doctor's guidance. For specific costs, it is recommended to consult local hospitals or authorized pharmacies. In some regions, medical insurance policies may cover part of the cost. Patients can bring relevant medical records to the medical insurance department to inquire about reimbursement conditions.

Main Factors Influencing Price

Drug Specifications

Osimertinib is available in 40mg and 80mg specifications. Prices differ based on the specification, with the 80mg dosage typically costing more due to its higher dose.

Purchase Channels

Prices may vary between hospitals, insurance-designated pharmacies, and other authorized channels. It is essential to purchase through legal channels and avoid using drugs from unverified sources.

Medical Insurance Policies

In some regions, Osimertinib is included in medical insurance reimbursement, but specific conditions must be met (e.g., confirmation of EGFR-sensitive mutations via genetic testing, prior treatment records, etc.). The actual out-of-pocket cost may be significantly reduced.

Other Considerations

Drug Assistance Programs

Some charitable organizations or pharmaceutical companies provide drug assistance programs for patients facing financial difficulties. For specific application procedures, consult the attending physician or relevant organizations.

Generic Alternatives

In some countries or regions, generic versions of Osimertinib may be available at a lower price than the original drug. However, it is crucial to ensure the quality and safety of the medication.

Medication Guidance

Lucius Pharmaceuticals Osimertinib is indicated for patients with EGFR mutation-positive non-small cell lung cancer. Before use, mutation status must be confirmed through genetic testing, and an individualized treatment plan should be developed based on the disease stage and prior treatment history. Common adverse reactions include diarrhea and rash. Regular follow-ups and monitoring of liver and kidney function, electrocardiograms, and other indicators are necessary. If severe adverse reactions occur (e.g., interstitial lung disease, QT interval prolongation), discontinue the drug immediately and seek medical attention.

Important Reminder: Any adjustments to the medication (e.g., dosage, treatment course) must be made under a doctor's supervision. Do not discontinue or alter the treatment plan on your own.